Researchers At South Korean Lab Make Advance In Fight Against Neglected Tropical Diseases

VOA News reports on a scientific breakthrough, which researchers call a “game changer” for developing new drugs, developed at Institut Pasteur Korea [IPK], a South Korean branch of the 124-year-old French research institute that is developing new drugs to combat diseases mainly affecting developing countries, including neglected tropical diseases (NTDs). “Combining imaging technology and biotechnology, scientists are now able to witness infections as they occur, in real time,” VOA writes.

Ulf Nehrbass, chief executive officer of IPK, said that giant for-profit pharmaceutical companies “devote the bulk of their research budgets to finding blockbuster drugs, which could ring up billions of dollars in profits,” but ignore the need for effective drugs targeting neglected diseases, VOA notes. “There have been breakthroughs in fighting some of the world’s most serious and common diseases, thanks to start-up funding from South Korea’s science ministry, along with contributions from non-government groups in the United States, France and other countries,” VOA writes (Herman, 9/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.